Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP912317.RAuKsFhSGnN1hw7zrTJUOZYMnHnOnu4SM3E7y-ZWi3UXE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP912317.RAuKsFhSGnN1hw7zrTJUOZYMnHnOnu4SM3E7y-ZWi3UXE130_assertion type Assertion NP912317.RAuKsFhSGnN1hw7zrTJUOZYMnHnOnu4SM3E7y-ZWi3UXE130_head.
- NP912317.RAuKsFhSGnN1hw7zrTJUOZYMnHnOnu4SM3E7y-ZWi3UXE130_assertion description "[These data provide compelling evidence that 17-AAG may be effective in the treatment of c-kit-related diseases including mastocytosis, GISTs, mast cell leukemia, subtypes of acute myelogenous leukemia, and testicular cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP912317.RAuKsFhSGnN1hw7zrTJUOZYMnHnOnu4SM3E7y-ZWi3UXE130_provenance.
- NP912317.RAuKsFhSGnN1hw7zrTJUOZYMnHnOnu4SM3E7y-ZWi3UXE130_assertion evidence source_evidence_literature NP912317.RAuKsFhSGnN1hw7zrTJUOZYMnHnOnu4SM3E7y-ZWi3UXE130_provenance.
- NP912317.RAuKsFhSGnN1hw7zrTJUOZYMnHnOnu4SM3E7y-ZWi3UXE130_assertion SIO_000772 14551138 NP912317.RAuKsFhSGnN1hw7zrTJUOZYMnHnOnu4SM3E7y-ZWi3UXE130_provenance.
- NP912317.RAuKsFhSGnN1hw7zrTJUOZYMnHnOnu4SM3E7y-ZWi3UXE130_assertion wasDerivedFrom befree-20140225 NP912317.RAuKsFhSGnN1hw7zrTJUOZYMnHnOnu4SM3E7y-ZWi3UXE130_provenance.
- NP912317.RAuKsFhSGnN1hw7zrTJUOZYMnHnOnu4SM3E7y-ZWi3UXE130_assertion wasGeneratedBy ECO_0000203 NP912317.RAuKsFhSGnN1hw7zrTJUOZYMnHnOnu4SM3E7y-ZWi3UXE130_provenance.